Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
Gradually increased to a maximum dose of 2.0 mg weekly. Common side effects include nausea, vomiting, diarrhea, and constipation. Consult your healthcare provider or the Ozempic medication guide ...
Ozempic should not be prescribed solely for weight loss ... Agency (MHRA), the dose may then be increased in at least four-week intervals up to the maximum dose of 15mg per week. Women using oral ...
BBC Good Food on MSN5d
Weight loss drugs – are they right for you?Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback